Development of a three-dimensional (3D) bioprinted in vitro model of cutaneous carcinoma.
Agata Kurzyk, Joanna Miłoszewska, Anna Szumera-Ciećkiewicz, Magdalena Chechlińska
01
Role of prolyl hydroxylases genes in Head and Neck Squamous Cell Carcinoma.
Julia Ostapowicz 1,3,5, Kamila Ostrowska 2,3,5, Agnieszka A. Rawłuszko-Wieczorek 4, Bartosz Wojtera 2,5, Sabina Koczot 2, Wojciech Golusiński 2, Wiktoria M. Suchorska 1,3
02
The role of ID3 transcription factor in growth, differentiation and migration of rhabdomyosarcoma.
Klaudia Skrzypek, Karolina Bąk, Marcin Majka
03
Chloride intracellular channels as potential head and neck cancer biomarkers: investigation of tissue mRNA expression.
Bartosz Wojtera 1,2,4, Julia Ostapowicz 1,2,3,4, Kamila Ostrowska 1,2,4, Wiktoria Suchorska 2,3, Mateusz Szewczyk 1, Wojciech Golusiński 1
04
Tumor-only mutation detection pipeline optimization - based on data from seqencing of chondrosarcoma.
Agnieszka E. Zając 1, Jakub Piątkowski 2, Paweł Golik 2,3, Paweł Teterycz 1, Anna Szumera-Ciećkiewicz 4,5, Anna M. Czarnecka 1,6, Piotr Rutkowski 1
05
Macrophage polarization as a model to study tumor immunomodulation by CpG-siSTAT3 therapeutics.
Sara Molenda 1,2, Agata Sikorska 1,2, Mariusz Kaczmarek 1,2, Hanna Dams-Kozłowska 1,2
06
Generation of spheroidal 3D models of cancers for the analysis of the activity of oligonucleotherapeutic stimulating the cGAS-STING and RIG-I/MAVS pathways.
Natalia Guźniczak 1,2, Marek Giers 1,2, Katarzyna Kaczmarek 1,2, Marcel Mohr 1,2, Daria Szczepaniak 1,2, Hanna Dams-Kozłowska 1,2
07
her2-targeted silk nanospheres as a delivery system for photodynamic therapy.
Wachirawit Udomsak 1,2, Julia Pospieszna 1,2, Tomasz Deptuch 2,3, Kamil Kucharczyk 2,3, Małgorzata Kucinska 1, Marek Murias1,*,#, Hanna Dams-Kozlowska 2,3,*,#
08
Biocompatible carriers made of bioengineered MS2-type silk for the delivery of therapeutic nucleic acids for cancer treatment.
Tomasz Deptuch 1, 2, Sara Molenda 1,2, Agata Sikorski 1,2, Kamil Kucharczyk 1,2, Anna Florczak 1,2, Hanna Dams-Kozlowska 1, 2
09
Genomic alterations in unresactable soft tissue sarcomas.
Klaudia Bobak 1, Andrzej Tysarowski 2, Katarzyna Seliga 2, Mateusz J. Spałek 1,3, Anna Szumera-Ciećkiewicz 4,5, Kamil Sokół 4, Michał Wągrodzki 4, Hanna Koseła-Paterczyk 1, Piotr Rutkowski 1, Anna M. Czarnecka 1,6
10
MMPs-responsive silk spheres for targeted drug release within tumor microenvironment.
Kamil Kucharczyk 1,2, Anna Florczak 1,2, Alicja Kaminska 1, Natalia Guzniczak 1,2, Hanna Dams-Kozlowska 1,2
11
AptCTLA-4-siRNA aptamer as a therapeutic agent in cancer immunotherapy.
Sikorska A. 1, Molenda S. 1, Kaczmarek M. 1,2, Pawlak P. 3, Dams-Kozlowska H. 1,2
12
Silk spheres targeting VEGF receptors for delivery of therapeutic oligonucleotides – a new approach for cancer treatment.
Patryk Lorenc 1, Tomasz Deptuch 1,2, Hanna Dams-Kozłowska 1,2, Anna Florczak 1,2
13
Cancer stem cells as a potential target in the rhabdomyosarcoma treatment.
Marta Kot, Wojciech Kowalczyk, Patrycja Malawska, Monika Nowakowska, Marcin Majka
14
ZNF273 is involved in the development of Lung Squamous Cell Carcinoma.
Marta Machnik 1,2, Sara Molenda 1,2, Joanna Sobocińska 1,3, Anna Florczak 1,2, Urszula Oleksiewicz 1,2
15
miR-27b-5p: a short non-coding RNA with the potential to influence the immune response in the head and neck squamous cell carcinoma.
Joanna Kozłowska-Masłoń 1,2,3, Tomasz Kolenda 1,2, Izabela Makałowska 3, Katarzyna Lamperska 1,2
16
Molecular markers of malignant melanoma transformation.
Agata Kubicka 1, Violetta Filas 1,2, Andrzej Marszałek 1,2
17
The Influence of YRNAs on HPV Infection and HNSCC Development.
Kacper Guglas 1,2, Tomasz Kolenda 1, Joanna Kozłowska-Masłoń 1,3, Patricia Severino 4, Anna Teresiak 1, Renata Bliźniak 1, Katarzyna Lamperska 1
18
TLR7 agonist changes tumor vasculature in a dose-dependent manner.
Jarosz-Biej M, Czapla J, Ciepła J, Smolarczyk R, Drzyzga A, Matuszczak S, Pilny E, Cichoń T
19
What role does Musashi-1 play in Uterine Corpus Endometrial Carcinoma?
Anna Jaworska 1,2*, Mariusz Kaczmarek 1,3
20
The expression od TLCD1 in breast cancer cells with different membrane receptors profile.
Justyna Sobocińska
21
The gut barrier functionality significantly correlates with the gut microbiome composition and response to the anti-PD-1 immunotherapy in the Polish cohort of melanoma patients.
Bernadeta Pietrzak 1, Katarzyna Tomela 2, Łukasz Galus 3, Artur Szwengiel 4, Agnieszka Olejnik-Schmidt 1, Jacek Mackiewicz 3, Mariusz Kaczmarek 2,5, Andrzej Mackiewicz 2,5, Marcin Schmidt 1
22